Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium-Reference-Cited by-同舟云学术

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

Published:2008-09-29 Issue:3 Volume:43 Page:245-251
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

von Bonin M,Stölzel F,Goedecke A,Richter K,Wuschek N,Hölig K,Platzbecker U,Illmer T,Schaich M,Schetelig J,Kiani A,Ordemann R,Ehninger G,Schmitz M,Bornhäuser M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2008316.pdf

Reference20 articles.

1. Bacigalupo A . Management of acute graft-versus-host disease. Br J Haematol 2007; 137: 87–98.

2. Weisdorf D . GVHD—the nuts and bolts. Hematology Am Soc Hematol Educ Program 2007; 2007: 62–67.

3. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–147.

4. Aggarwal S, Pittenger MF . Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815–1822.

5. Le Blanc K, Ringdén O . Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007; 262: 509–525.

Cited by 262 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New investigational drugs for steroid-refractory acute graft-versus-host disease: a review of the literature;Expert Opinion on Investigational Drugs;2024-07-09

2. Alexander Friedenstein, Mesenchymal Stem Cells, Shifting Paradigms and Euphemisms;Bioengineering;2024-05-23

3. International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft-versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges;Cytotherapy;2024-05

4. Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?;American Journal of Respiratory and Critical Care Medicine;2024-04-01

5. TWIST1 and TSG6 are coordinately regulated and function as potency biomarkers in human MSCs;Science Advances;2023-11-10